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The mutation Gly99lys (E99K) in the cardiac actin (ACTC) gene was reported
to cause Hypertrophic Cardiomyopathy in extensive clinical studies. Trans-
genic (TG) mice expressing 50% E99K mutant cardiac actin in their hearts
were generated and studied. The mice show high mortality between 28 and
45 days old (70% females, 34% males).
Thin filaments reconstituted with purified mouse f-actin from the survivors and
human heart tropomyosin and troponin were studied by in vitro motility assay.
The E99K thin filaments were 2.55 0.6 times more Ca2þ sensitive than NTG
thin filaments (p ¼ 0.05). E99K actin thin filaments also exhibited a reduced
response to troponin dephosphorylation (EC50 E99K/E99KdP ¼ 1.1 5 0.1
compared with 3.05 0.3 for NTG /NTGdP).
7 month-old E99K TG mice (n¼9) and their NTG littermates (n¼7) were
studied using in vivo cine MRI. Abnormal cardiac morphology and signif-
icantly lower ejection fractions (56.5 vs. 65.2%) and reduced stroke vol-
umes (26.0 vs. 42.3 ml) were observed in TG mice. Peak LV ejection
rates were also reduced (188 5 41 vs. 252 5 49 ml/min). LV mass
was similar between groups, but septal wall thickness was increased (1.5
vs. 1.0 mm).
Left ventricular function of 9 month-old female E99K NTG (n¼4) and TG
(n¼5) mice were studied with an in vivo conductance catheter. In TGmice ejec-
tion fraction was 20.2% less, end-diastolic pressure was 39.6% higher and
relaxation rate was 50.0% slower.
We conclude that the basic effect of E99K mutation is increased Ca2þ-sensitiv-
ity and blunted response to troponin dephosphorylation and this leads to the
high rate of sudden death at early ages, alterations to cardiac function and hy-
pertrophy as observed in patients with hypertrophic cardiomyopathy.
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At the myofilament level, increases in cardiac output in response to in-
creased sympathetic tone is achieved via protein kinase A (PKA)-mediated
phosphorylation of cardiac myosin binding protein C (cMyBP-C) and car-
diac troponin I (cTnI). However, despite the physiological importance of
b-adrenergic stimulation in maintaining cardiac performance, the respective
roles of cMyBP-C and cTnI phosphorylations in the myofibrillar force re-
sponse of working myocardium are not completely understood. Using trans-
genic mouse lines either (1) expressing mutant non-phosphorylatable cTnI
(cTnIala5) or (2) expressing cTnIala5 on a cMyBP-C null background
(cMyBP-C-/-/cTnIala5), we assessed the calcium sensitivity of force
(pCa50) and the rate of force redevelopment (ktr) in skinned myocardial
preparations following treatment with PKA and/or reconstitution with puri-
fied recombinant cMyBP-C. Before mechanical measurements, all prepara-
tions were treated with 2,3-butanedione monoxime (BDM) to reduce regu-
latory light chain (RLC) phosphorylation to near zero. In cTnIala5
myocardium, PKA phosphorylation of cMyBP-C resulted in a decrease in
pCa50 and an increase in ktr. However, no changes in either variable
were observed in cMyBP-C-/-/cTnIala5 myocardium in response to PKA
treatment. Following reconstitution of cMyBP-C-/-/cTnIala5 myocardium
with cMyBP-C, ktr decreased to the values observed in cTnIala5 myocar-
dium, demonstrating that incorporation of cMyBP-C slowed the rates of
cross-bridge attachment and transitions to strongly bound, force generating
states. Subsequent treatment of reconstituted cMyBP-C-/-/cTnIala5 myocar-
dium with PKA produced a rightward shift in pCa50 and an increase in
ktr. Together, these results suggest that in the absence of cTnI phosphory-
lation (and RLC phosphorylation), PKA phosphorylation of cMyBP-C de-
creases calcium sensitivity of force and speeds cross-bridge cycling kinetics
in murine myocardium.
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Cardiac myosin binding protein-C is a regulatory protein associated with sarco-
mere A-bands that modulates actomyosin interactions in a phosphorylation de-pendent manner. The MyBP-C motif, a highly conserved sequence in the N-ter-
minus of cMyBP-C, contains three to five protein kinase A (PKA)
phosphorylation sites, depending on species. In the human isoform, three PKA
sites have been identified (S275, S284, and S304). Three homologous sites exist
in the murine isoform (S273, S282, and S302) along with a potential fourth site,
S307, which is not present in human cMyBP-C. In this study, we investigated the
effects of PKA phosphorylation of murine cMyBP-C by treating a recombinant
protein, C1C2 (which contains the C1, motif, and C2 domains), with PKA and
assessing phosphorylation levels using IEF gels, ProQ Diamond staining, and
mass spectrometry. The wild-type C1C2 has a pI of ~8 and PKA treatment
(C1C2P) shifted the pI to ~5-6 as determined by 1-D IEF gels. A mutant
C1C2 (3S/D), containing aspartic acid for serine substitutions at S273D,
S282D, and S302D, was still phosphorylated upon treatment with PKA as in-
dicated by increased ProQ Diamond staining. However, a mutant 4S/D C1C2
(containing the additional mutation S307D) showed a pI near that of C1C2P
and was not further phosphorylated by PKA. Mass spectrometry and MASCOT
analysis of C1C2P confirmed that S307 was phosphorylated by PKA. These re-
sults suggest that murine S307 can be phosphorylated in vitro. Further studies
are needed to investigate the phosphorylation state of murine cMyBP-C in vivo.
Supported by NIH HL080367 to SPH and a NSF Graduate Research Fellowship
to JFS.
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Myosin Binding Protein C (MyBP-C) is a sarcomeric protein that has both
structural and regulatory roles in striated muscle contraction. Cardiac (c) iso-
forms of MyBP-C can be phosphorylated by protein kinase A (PKA) at three
to five sites within a unique regulatory region referred to as the MyBP-C
motif. We have previously shown, using permeabilized rat trabeculae, that
the recombinant protein C1C2, which contains the motif, significantly in-
creased Ca2þ sensitivity of force and increased rates of tension redevelop-
ment (ktr) at submaximal [Ca2þ]. To investigate whether these effects are
modulated by phosphorylation of the motif, we used the catalytic subunit
of PKA to phosphorylate C1C2. In addition, we used site directed mutagen-
esis to mutate three key serine residues (Ser273, 282, 302) to aspartic acids
to mimic phosphorylation at these sites. Results demonstrated that either
10uM phosphorylated C1C2 (C1C2P) or 10uM phospho-mimic C1C2
(C1C23S/D) increased Ca2þ sensitivity of force and increased rates of ten-
sion redevelopment (ktr) at submaximal [Ca2þ]. However, the phospho-
mimic C1C23S/D was more effective than C1C2P in producing these effects.
Together these results indicate that the 3 Ser to Asp phospho-mimic does not
fully mimic effects of PKA phosphorylation of C1C2 and that the functional
effects of C1C2 in permeabilized cardiac trabeculae are mediated at least in
part through phosphorylation-independent mechanisms. Supported by NIH
HL080367.
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Tanganyika Wilder, Aaron C. Hinken, R. John Solaro.
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Post-translational modification of troponin (Tn) and other myofilament proteins
by protein kinase C (PKC) isozymes plays a prominent role in regulating myo-
cardial contraction. Conventionally, phosphorylation of conserved serine and
threonine residues in the c-terminus activates PKCdelta, a novel calcium inde-
pendent isozyme. Several recent investigations including our work (Sumandea
et al. J Biol Chem. 2008;283(33):22680-9) have led to the probability of alter-
native activation of PKCdelta by tyrosine residue phosphorylation through a re-
dox-sensitive mechanism. Previous work determined PKCdelta phosphoryla-
tion of adult, cardiac rat myocytes in vitro reduces skinned myocyte tension
generation at sub-maximum with no change at maximum calcium concentra-
tions. Conversely, tyrosine phosphorylated PKCdelta reduces the maximal
Ca-activated tension with no decrease in submaximal tension production. Bio-
chemical data indicated a shift in TnI residue targeting with tyrosine phosphor-
ylated PKCdelta from exclusive phosphorylation of S23/24, to include T144.
To test the hypothesis that kinase targeting to TnI-T144 was sufficient to blunt
effects of conventional PKCdelta targeting to TnI-S23/24, myofibrillar function
was assessed following exchange of TnI with pseudo-phosphorylated residues.
Pseudo-phosphorylation at residues S23/24 decreased Ca-sensitivity of force
production and increased tension cost. Pseudo-phosphorylation at TnI-144
had minimal affect on mechanical parameters. However, the combination of
pseudo-phosphorylations at residues S23/24 and T144 did not successfully
blunt desensitization. Further biochemical assessments have determined
Tuesday, March 3, 2009 501adifferential PKCdelta targeting to multiple myofibrillar proteins other than TnI.
Further elucidation of alternative PKCdelta signaling to the myofilments is on-
going. Our results suggest Src-dependent phosphorylation of PKCdelta consti-
tutes an alternative mechanism that allows for stimulus-specific PKCdelta ezy-
mology and myofibrillar targeting within the myocardium.
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It is well known that protein kinase A (PKA) decreases Ca2þ sensitivity in car-
diac muscle via phosphorylation of troponin I (TnI). In the present study, we di-
rectly tested whether PKA-based phosphorylation of cardiac TnI universally
modulates Ca2þ sensitivity regardless of the type ofmuscle, by taking advantage
of our Tn exchange technique (Terui et al., J Gen. Physiol. 131;275-283:2008).
Troponins were extracted from porcine ventricular and rabbit fast skeletal mus-
cles (Ca2þ sensitivity: former < latter). Without Tn exchange, PKA decreased
Ca2þ sensitivity in cardiac (porcine ventricular) muscle, associated with en-
hanced phosphorylation of TnI. Reconstitution of cardiac muscle with the skel-
etal Tn complex (sTn) not only increasedCa2þ sensitivity but abolished the PKA
effect, suggesting that phosphorylation of TnI, but not ofmyosin-binding protein
C, is primarily responsible for the PKA-based reduction in Ca2þ sensitivity. Re-
constitution of rabbit psoasmusclewith the cardiac Tn complex (cTn) decreased
Ca2þ sensitivity, as previously reported by us (Terui et al., J Gen. Physiol.
131;275-283:2008). PKA decreased Ca2þ sensitivity in cTn-reconstituted skel-
etal muscle, and subsequent exchange for sTn restored Ca2þ sensitivity to the
original level. A similar result was obtained when skeletal muscle was reconsti-
tutedwith the hybridTn complex (i.e., cTnI-cTnC-sTnT), suggesting that the tro-
ponin I-C complex, but not TnT, is essential for PKA-based modulation of Ca2þ
sensitivity. Thesefindings support the notion that PKA-based phosphorylation of
TnI universally modulates Ca2þ sensitivity regardless of the type of muscle.
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Cardiac Troponin I Threonine 144 phosphorylation: impact on myofila-
ment function
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Threonine 144 (T144) in the inhibitory region of cardiac troponin I (cTnI)
is an important site for PKC mediated phosphorylation in the heart. In ad-
dition, presence of this residue is sufficient to impart length dependent ac-
tivation (LDA) properties onto the cardiac sarcomere (Tachampa Circ. Res.,
2008). Here we studied the functional impact of a charge mutation so as to
mimic phosphorylation of this residue (T144E). Wild-type (WT) or cTnI-
T144E containing recombinant troponin (cTn) complexes were exchanged
for endogenous cTn in skinned rat cardiac trabeculae. Force and ATPase
activity were measured as function of [Ca2þ] at short (2.0 mm) or long
(2.2 mm) sarcomere length. T144E induced decreased maximum force de-
velopment (Fmax) and Calcium sensitivity (EC50), increased cross-bridgeWT cTn T144E cTn
EC50 2.0 (mM) 4.05 0.3 5.9 5 0.4
EC50 2.2 (mM) 3.55 0.2 5.2 5 0.3
Fmax 2.0 (mN/mm2) 25.15 4.7 13.05 1.7
Fmax 2.2 (mN/mm2) 37.25 4.7 24.55 2.7
Tension cost 2.0 7.75 0.5 12.05 1.3
Tension cost 2.2 6.35 0.5 9.4 5 1.2
DEC50 0.65 0.1 0.7 5 0.2cycling rate (tension cost) but, in contrast, did not affect LDA (DEC50).
We conclude that T144E affects cross-bridge cycling and recruitment inde-
pendent of sarcomere length.
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Effects of Cardiac Troponin C Mutants on TnC-TnI interaction and its
modulation by PKA phosphorylation
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University of Washington, Seattle, WA, USA.We are considering several cardiac TnC mutants as potential therapeutic
strategies for cardiomyopathies. To judge their potential to improve in
situ function it is important to understand how these mutants affect TnC-
TnI interaction and its modulation by PKA-mediated phosphorylation of
TnI Ser 23, Ser 24. In this study, we are characterizing two cardiac TnC
mutations, Leu48Glu (L48Q) and Ile61Glu (I61Q), with increased and de-
creased (respectively) Ca2þ binding affinity. In previous studies we showed
these mutations resulted in increased (L48Q) and decreased (I61Q) Ca2þ
sensitivity of steady state force in skinned rat trabeculae. To determine if
these changes in Ca2þ sensitivity were due to altered TnC-TnI interactions
we generated a structural marker by attaching IANBD to Cys84 in the N-
lobe of cTnC. Half-maximal IANBD fluorescence saturation of Ca2þ bind-
ing occurred at pCa7.42 for L48Q cTnC, 7.38 for wild-type (WT) cTnC
and 7.30 for I61Q cTnC. In both the absence and presence of saturating
Ca2þ (0.6 mM TnC) IANBD fluorescence increased with increasing TnI
and saturated at different [TnI] in the order L48Q, WT, I61Q. Fluorescence
half-maximal saturation occurred at 0.26mM(saturating Ca2þ) and 0.25 mM
(no Ca2þ)TnI for L48Q cTnC, 0.78 mM and 0.49mM for WT cTnC , and
1.45 mM and 0.69 mM I61Q cTnC according to the exponential function
fit of the data. However, preliminary experiments suggest that when PKA
phosphorylated [cTnI] was titrated to cTnC, in both the absence and pres-
ence of saturating Ca2þ, IANBD fluorescence enhancement with L48Q may
be impaired. The data thus far suggest that single amino acid mutations that
alter Ca2þ binding affinity of TnC can influence interaction with TnI and
its modulation by PKA mediated phosphorylation of Ser 23, Ser 24.
Supported by HL65497 to MR.
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Analysis of Cardiac Myofibrillar Troponin I Phosphorylation in Normal
and Failing Human Hearts Using Phos-Tags
Andrew E. Messer, Clare E. Gallon, Steven B. Marston.
Imperial College - NHLI, London, United Kingdom.
Recently, we have used phosphate-affinity SDS-PAGE gels containing Phos-
tag-acrylamide (a phosphate-chelating molecule), to determine the level of car-
diac troponin I (cTnI) phosphorylation in human myofibrillar extracts. The
Phos-tag moiety binds to, and retards, the mobility of phosphoproteins through
the gel and results in the separation of the phosphoprotein bands according to
their phosphorylation level.
Samples from time-courses of in-vitro PKA catalytic subunit-treated recombi-
nant human cTnI andmyofibrillar extracts from non-failing donor, hypertrophic
obstructive cardiomyopathy (HOCM) and end-stage failing human heart tissue
were analysed by phosphate-affinity SDS-PAGE. Separate gel bands corre-
sponding to 1P, 2P, 3P, 4P and 5P cTnI were observed for the PKA-treated re-
combinant cTnI. Western blotting probed with the anti-cTnI antibody 14G5
and several different site specific phospho-cTnI antibodies demonstrated that
all five of these phospho-species bound to a Ser24P-specific antibody, while
a Thr144P-specific antibody only reacted with the 3P, 4P and 5P phospho-
species of cTnI.
We observed 3 phospho-species of cTnI in the human heart tissue extracts,
which correspond to 0P, 1P and 2P cTnI. Ratios of 0P cTnI were signifi-
cantly higher in failing and HOCM (both 6354%) compared to donor
(852%) while ratios of 2P were significantly lower (failing ¼ 652%,
HOCM ¼ 852%, donor 7356%). Western blots demonstrated that in hu-
man heart cTnI phosphorylation of Ser23/24 was mainly present in the 2P
species (with a very small proportion in the 1P species) and that there was
no phosphorylation at Thr144. Calculated levels of total cTnI phosphoryla-
tion in both HOCM (0.3750.03, n¼50, p<0.0001) and failing heart
(0.3850.03, n¼24, p<0.0001) were significantly reduced from levels in do-
nor heart (1.6550.04, n¼38) and were comparable to previously deter-
mined measurements obtained from Pro-Q Diamond phosphoprotein gel
staining.
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Effect of Troponin I Ser23/24 Bis-Phosphorylation on Ca2þ-Sensitivity is
Dependent on PKA Phosphorylation of Other Contractile Proteins
Viola Kooij, Jolanda van der Velden, Ger J.M. Stienen.
Laboratory for Physiology, Institute for Cardiovascular Research, VU
University Medical Center, Amsterdam, Netherlands.
Upon b-adrenergic stimulation, protein kinase A (PKA) enhances cardiac Tro-
ponin I (cTnI) phosphorylation at ser23/24. PKA treatment leads to a decrease
in myofilament Ca2þ-sensitivity. However, the specific effect of PKA-mediated
phosphorylation of cTnI in human myocardium is unclear since PKA phosphor-
ylates a broader set of contractile proteins, in particular myosin binding protein
C (cMyBP-C).
